Related Experiment Videos
An attempt to structurally convert mu-selective morphine toward delta-receptor binding: dimerization based on
1Osaka University of Pharmaceutical Sciences, Japan.
European Journal of Pharmacology
|June 12, 1990
Summary
Researchers synthesized dimeric morphine molecules to understand opioid receptor binding. The NOR2 molecule showed preference for delta-opioid receptors, while NOR3 acted as an antagonist, offering insights into receptor selectivity.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Mu- and delta-opioid receptors are key targets for pain management.
- Understanding ligand selectivity is crucial for developing targeted therapeutics.
- Endogenous enkephalins exhibit receptor selectivity, suggesting structural determinants.
Purpose of the Study:
- To investigate the substrate specificities of mu- and delta-opioid receptors.
- To explore the relationship between molecular conformation and opioid receptor selectivity.
- To synthesize and characterize dimeric morphine analogs.
Main Methods:
- Dimerization of the mu-specific morphine molecule.
- Synthesis of NOR2 ([normorphine]N-CH2-CH2-N[normorphine]) and NOR3 ([normorphine]N-CH2-CH2-CH2-N[normorphine]).
- Assessment of binding affinity and functional activity at opioid receptors.
Main Results:
- The synthesized NOR2 molecule demonstrated agonist activity.
- NOR2 showed a binding preference for the delta-opioid receptor over the mu-opioid receptor.
- NOR3 exhibited antagonist activity, suggesting differential effects based on linker length.
Conclusions:
- Dimerization of morphine can alter its receptor binding profile.
- The length of the linker in dimeric morphine analogs influences their activity and selectivity.
- These findings provide insights into the structural basis of opioid receptor subtype specificity.